Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

5.00

-0.06 (-1.19%)

At close: Oct 9, 2025, 4:00 PM EDT

4.980

-0.020 (-0.40%)

After-hours: Oct 9, 2025, 4:02 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Adeno-Associated Viruses-based Gene Therapies	15.45M	Log In
Adeno-Associated Viruses-based Gene Therapies Growth	517.55%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.